DPDikwata Thabiso Phofa

Dikwata Thabiso Phofa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dikwata Thabiso Phofa has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genetic determinants of multi-drug resistance in Acinetobacter baumannii at an academic hospital in Pretoria, South Africa

    by Noel-David Nogbou, Dikwata Thabiso Phofa, Maphoshane Nchabeleng, Andrew Munyalo Musyoki

    Antimicrobial resistance is now globally recognised as the greatest threat to human health. Acinetobacter baumanniis’ ( A. baumannii ) clinical significance has been driven by its ability to obtain and transmit antimicrobial resistance factors. In South Africa, A. baumannii is a leading cause of healthcare associated infections (HAI). In this study, we investigated the genetic determinants of multi-drug resistant A. baumannii (MDRAB) at a teaching hospital in Pretoria, South Africa. One hundred non repetitive isolates of A. baumannii were collected for the study at Dr George Mukhari Tertiary Laboratory (DGMTL). Antimicrobial susceptibility testing was performed using the VITEK2 system (bioMerieux, France). The prevalence of common resistance associated genes and AdeABC efflux pump system associated genes were investigated using conventional PCR. Genetic relatedness of isolates was then determined using rep-PCR. Seventy (70) of 100 isolates collected were confirmed to be multi-drug resistant and were bla OXA51 positive. Phenotypically, the isolates where resistant to almost all tested antibiotics. However, one isolate showed intermediate susceptibility to tigecycline while all were susceptible to colistin. Oxacillinase encoding gene bla OXA-23 was the most detected at 99% and only 1% was positive for bla OXA-40 . The PCR results for metallo-betalactamase (MBL) encoding genes showed that MBL bla VIM was the most frequently detected at 86% and bla SIM-1 at 3% was the least detected. Out of 70 isolates, 56 isolates had the required gene combination for an active efflux pump. The most prevalent clone was clone A at 69% of the isolates. Regarding treatment; colistin and tigecycline are the most effective against strains encountered at DGMTL as all tested carbapenems seem to have lost their effectiveness. The major genotypic determinants for drug resistances are oxacillinases: bla OXA-51 (100%) and bla OXA-23 (99%). The study reports for the first time, bla OXA-40 and bla SIM-1 detection in A. baumannii in South Africa.